23 Recruiting Hepatocellular Carcinoma (HCC) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Recruiting Hepatocellular Carcinoma (HCC) Studies
Streamlined Resin Y90 Radiation Segmentectomy for Small HCC
📍 UNC Hospitals — Chapel Hill, North Carolina
View Study & Checklist ➔A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE
📍 Research Site — Aurora, Colorado
View Study & Checklist ➔Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin
📍 Zuckerberg San Francisco General Hospital (ZSFG) — San Francisco, California
View Study & Checklist ➔Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
📍 Juravinski Hospital — Hamilton, Ontario
View Study & Checklist ➔Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant
📍 London Health Sciences Centre — London, Ontario
View Study & Checklist ➔Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
📍 VA Palo Alto Health Care System — Palo Alto, California
View Study & Checklist ➔Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
📍 Oncology Physicians Network (OPN) - Los Alamitos /OPN Healthcare — Glendale, California
View Study & Checklist ➔A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
📍 Local Institution - 0137 — Duarte, California
View Study & Checklist ➔A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
📍 City of Hope Nat Medical Ctr — Duarte, California
View Study & Checklist ➔Computer Guided Microwave Liver Ablation
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
📍 Research Facility — Birmingham, Alabama
View Study & Checklist ➔Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔PSMA PET for the Staging and Management of Hepatocellular Carcinoma
📍 VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California
View Study & Checklist ➔